Sesen Bio Received an Update from the FDA and Evoke Pharma Reported Great Earnings 💊

Sesen Bio Received an Update from the FDA and Evoke Pharma Reported Great Earnings

Sesen Bio

Sesen Bio is a small cap biotechnology company located in Cambridge, Massachusetts, where there are many prestigious medical universities. They have a market cap of $413.566 million dollars, and they classify as a penny stock.

On Friday, the FDA decided that they couldn’t approve Sesen’s application for their drug Vicineum, which is a bladder cancer drug. Along with this, the FDA sent a recommendation letter for what needed to be fixed, which shocked investors. This was a key drug for the company’s future, so it wasn’t a surprise when its share price fell 82% to below a dollar, while also being halted for volatility. At the end of the day, Sesen closed at $2.11, a fraction of its share price on Thursday.  

Evoke Pharma

Evoke Pharma is a drug company that develops medicines for gastroenterological diseases. They are based in a suburb of San Diego, California, and they are a micro-cap company with a market capitalization of $43.378 million.

On Friday, Evoke announced their earnings for the quarter. They saw a net loss of 7 cents per share, which was an improvement from the previous quarter. Net sales also saw a jump as people were being prescribed their medications, and R&D costs saw a massive decrease due to the approval of their drug by the FDA. It was overall positive, and the same can be said about their stock price that day, with Evoke closing at 1.34 to end the day, up 19.64%.

I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.

Share:

More Posts

Get your daily Invstr Crunch

Get the market news and updates you need, delivered to your inbox or available on our daily podcast.

Risk Disclosure:

Invstr is not a bank and banking services are provided by Vast Bank, N.A.

Brokerage and Banking services are currently only available to U.S. residents.

Invstr app and web services are provided by Invstr Ltd. Advisory services are provided by Invstr Financial LLC, an investment adviser registered with the Securities Exchange Commission (SEC) details of which can be obtained here. Securities brokerage and custody services are provided by Apex Clearing, a broker dealer registered with the SEC and a member of FINRA and SIPC. There is no bank guarantee on securities and securities may lose value.

Investing involves risk and can lead to losses. Past performance does not guarantee future results.

Invstr app and web services are provided by Invstr Ltd. Invstr+ advisory services are provided by Invstr Financial LLC, an investment adviser registered with the Securities Exchange Commission (SEC). Securities brokerage and custody services are provided by Apex Clearing, a broker dealer registered with the SEC and a member of FINRA and SIPC. There is no bank guarantee on securities and securities may lose value. Vast Bank N.A. a nationally chartered bank and member of the FDIC, provides the banking products, including the products and services related to digital asset accounts. As with any asset, the value of Digital assets can go up or down and there can be a substantial risk that you lose money buying or holding digital assets. You should carefully consider whether trading or holding Digital assets is suitable for you in light of your financial condition. Your digital account does not support wallet to wallet transferring of your digital assets (i.e. cryptocurrencies) outside the platform. Any Digital Assets in your digital asset account are not insured by any government entities, including but not limited to FDIC or SIPC. The Invstr Visa® Debit Card is issued by Vast Bank, N.A. pursuant to a license from Visa U.S.A Inc and may be used everywhere Visa debit cards are accepted. Invstr Ltd, Invstr Financial LLC and Invstr Securities Ltd are subsidiaries of Marketspringpad Holdings (collectively “Invstr”) and Invstr is solely responsible for the application services and website content.

Watchlists provided when users first access the service are not a recommendation to invest. Instead they are provided to help users better navigate the service. Users are free to edit and create their own watchlists. From time to time, Invstr will suggest instruments solely based on an individual’s interest and the interest levels of the Invstr community.The statistical and portfolio builder models generated by Invstr do not reflect actual investment results and are not guarantees of future results.Comments provided by Invstr leaders, influencers or members of the Invstr Community are not recommendations and should not be construed as such.Invstr does not endorse the content or the positions posted by them. Their investment approach, and that of the models provided by Invstr, may be different from yours and may not be appropriate for you.